J Korean Fract Soc.  1999 Apr;12(2):446-451.

Scaphocapitate Fusion for Kienbock disease

• Yang JY
• Shin HD
• Ahn SR
• Rhee KJ
• Lee JK
• Choi JH

Abstract

We reviewed 14 patients treated with scaphocapitate fusion for Kienb.. ock's disease(Lichtman stage III) with mean follow-up of 26 months (ranging from 1 years to 5 year). There were five mens and nine womens. The mean age of patients at the time of operation was 46.1 years (ranging from thirty one to sixty). According to Lichtman's classification, All patients were stage III. Clinical assessments were evaluated using by pain relief, limitation in range of motion and clinical improvement. Radiologic assessment was evaluated by carpal height ratio. The mean range of motion is flexion 30 degree, extension 41 degree preoperatively, and flexion 29 degree, extension 41 degree postoperatively. The mean carpal height ratio is 0.49 preoperatively and 0.48 postoperatively. All of cases are relief of pain. Therefore radiographic and clinical satisfactory results were obtained. In conclusion, scaphocapitate fusion appear to be a very effective method for Lichtman stage III of symptomatic Kienb.. ock's disease.

Keyword

Luncate; Kienbock disease; scaphocapitate fusion

MeSH Terms

Classification
Female
Follow-Up Studies
Humans
Male
Osteonecrosis*
Range of Motion, Articular